Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Ascendis Pharma A/S (ASND) Discusses FDA Approval and Commercial Launch Plans for YUVIWEL Transcript
Ascendis Pharma A/S (ASND) Discusses FDA Approval and Commercial Launch Plans for YUVIWEL March 2, 2026 8:00 AM EST Chad Fugure - Vice President of Investor Relations Jan Mikkelsen - President, CEO, Member of Executive Board & Executive Director…
Natco Pharma launches Pomalidomide capsules in US
Natco Pharma has announced the launch of Pomalidomide Capsules, a generic version of Pomalyst, in the US market. This product, developed in partnership with Breckenridge Pharmaceutical, Inc., is indicated for the treatment of adult patients with…
Urogen Pharma Q4 Earnings Call Highlights
3 Bullish Biotech Stocks With Explosive Growth Trends Urogen Pharma NASDAQ: URGN executives used the company's fiscal 2025 earnings call to highlight early commercial momentum for newly launched Zusduri, continued growth from its established…
American Century Companies Inc. Buys 13,797 Shares of Ascendis Pharma A/S $ASND
American Century Companies Inc. lifted its stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 2.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional…
Urogen Pharma (NASDAQ:URGN) Given Buy Rating at D. Boral Capital
Urogen Pharma (NASDAQ:URGN - Get Free Report)'s stock had its 'buy' rating reissued by D. Boral Capital in a research note issued on Monday, Benzinga reports. They presently have a $33.00 price objective on the stock. D. Boral Capital's price…
Ascendis Pharma A/S (NASDAQ:ASND) Hits New 12-Month High - Here's What Happened
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report)'s stock price reached a new 52-week high on Monday. The stock traded as high as $242.44 and last traded at $242.09, with a volume of 1413069 shares changing hands. The stock had previously closed…
Urogen Pharma (NASDAQ:URGN) Posts Quarterly Earnings Results, Beats Expectations By $0.11 EPS
Urogen Pharma (NASDAQ:URGN - Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.54) EPS for the quarter, beating the consensus estimate of ($0.65) by $0.11, FiscalAI reports. The business had revenue of…
Rachel Reeves to insist she will stick with the plan at spring statement
News from The City, market updates plus comment and analysis from our business desk I would like to be emailed about offers, event and updates from Evening Standard. Read our privacy notice. The Government has the “right economic plan for…
Weight loss drug manufacturer announces €432 million investment at Irish plant
Danish weight-loss drug manufacturer Novo Nordisk is set to expand its Irish facility with a multi-million-euro investment. The company will begin producing an oral version of the injectable obesity drug Wegovy at its Athlone plant for markets…
Thermo Fisher Scientific: Recovery In Life Sciences Solutions (NYSE:TMO)
Thermo Fisher Scientific is reiterated as a 'buy' with a fair value estimate of $619 per share, reflecting confidence in its recovery and strategic positioning. TMO's acquisition of Clario Holdings for $8.875 billion is expected to enhance…
Column | Of course the 'Scrubs' reboot is millennial cringe. So is adult life now.
Twenty-six years ago, a young doctor named John Doris was approached by his former classmate Bill Lawrence, then a television writer, who proposed a sitcom based on Doris's life as an inexperienced intern. Doris said yes, with the stipulation that…
Stock Markets Suffer Major Meltdown as West Asia Crisis Intensifies
Mumbai: Stock market benchmark indices Sensex and Nifty nosedived over 1 per cent on Monday as investors' sentiment were hit hard following a sharp spike in crude oil prices amid escalating tensions in West Asia. Weak trends in global markets and…
Rachel Reeves to insist she will stick with the plan at spring statement
The Government has the “right economic plan for the country”, Rachel Reeves will insist at the spring statement. The Chancellor is expected to say the economy is “stronger and more secure” as a result of decisions taken…
Japan's Nikkei Stock Average Falls as US-Israel War with Iran Escalates
TOKYO, March 3 (Reuters) – Japan's Nikkei share average fell on Tuesday, as investors remained on edge for a second straight day following the U.S.-Israeli strikes on Iran. The Nikkei.N225 fell 1.2% to 57,384.38 as of 0135 GMT while the…
IDEXX Laboratories, Inc. (IDXX) Presents at 47th Annual Raymond James Institutional Investor Conference Prepared Remarks Transcript
IDEXX Laboratories, Inc. (IDXX) 47th Annual Raymond James Institutional Investor Conference March 2, 2026 9:15 AM EST Jay Mazelsky - President, CEO & Director Andrew Cooper - Raymond James & Associates, Inc., Research Division Raymond James &…
Receive a Daily briefing on Pharma Industry News
Get Started